Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

NCT00337493 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: mycophenolate mofetil [CellCept]
DRUG: mycophenolate mofetil [CellCept]
DRUG: Cyclosporine or tacrolimus
DRUG: Cyclosporine or tacrolimus

Sponsor

Hoffmann-La Roche